1-Palmitoyl-sn-glycero-3-phosphorycholine, (lyso-PPC)1-Palmitoyl-sn-glycero-3-phosphorycholine, (lyso-PPC)
Move your mouse over image or click to enlarge

1-Palmitoyl-sn-glycero-3-phosphorycholine, (lyso-PPC)


This product is a well-defined high purity lyso-phosphatidylcholine (PC) containing palmitic acid acylated to the sn-1 position and a hydroxyl group on the sn-2 position. lyso-PC is formed by the action of phospholipase A2 on phosphatidylcholine by hydrolyzing the fatty acid on the sn-2 position. lyso-PC has many cellular functions but it is quickly acylated or further degraded in living systems. It has been found to stimulate phagocytosis, change the surface properties of erythrocytes, and have pro-inflammatory and cell signaling properties. lyso-Lecithin induces demyelination of nerves in biological systems and can therefore be used to mimic some of the effects of demyelinating diseases.1 Lyso-PC activates the enzyme phospholipase C, which releases diacylglycerols and inositol triphosphate, thus mediating a number of different functions. lysophosphatidylcholine has also been shown to be protective against lethal sepsis in some studies. In endothelial membranes it produces a selective unresponsiveness to receptor-regulated endothelium-dependent vasodilators, causing atherosclerosis.2 lyso-PC has been demonstrated to induce a fibrillation-like arrhythmia in isolated cardiomyocytes.3 This high purity product has natural stereochemistry and is ideal as a standard and for biological systems.4
Cat# Size Price Qty Buy
1445 100 mg £137.10

Additional Information

Property Value or Rating
Product Size 100 mg
Manufacturer Matreya, LLC
Empirical Formula C24H50NO7P
CAS# 17364-16-8
Formula Weight 495.6
Solvent none
Source synthetic
Purity 98+%
Analytical Methods TLC
Natural Source Synthetic
Solubility methylene chloride, methanol
Physical Appearance A neat solid
Storage -20°C

1. R. Woodruff and R. Franklin “Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: A comparative study” Glia, vol. 25 pp. 216-228, 1999 
2. P. Henry et al. “Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins” Nature, vol. 344 pp. 160- 162, 1990 
3.E. Omerovic et al. “Pro-Arrhythmic Effects of Lysolecithin on Isolated Cardiomyocytes” Circulation, 2008;118:S_922 
4. A. Simonsen “Activation of Phospholipase A2 by Ternary Model Membranes” Biophysical Journal., vol. 94 pp. 3966-3975, 2008

Related Documents